Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169194 · ClinicalTrials.gov registry record
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
A clinical trial of Inflammatory Bowel Disease, sponsored by Johns Hopkins University.
- Active
- Registry status
- 2,400
- Enrollment target
- 1
- Study location
NCT01169194: Active study of Inflammatory Bowel Disease, sponsored by Johns Hopkins University.
NCT01169194 is a study of Inflammatory Bowel Disease that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 2,400 participants, above the 318-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (655% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01169194, a study of Inflammatory Bowel Disease, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,400 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hopkins or any local facility convenient to you.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2003-06 |
| Est. Completion | 2027-08 |
What the registry record for NCT01169194 still lists
NCT01169194 is an observational study that tracks outcomes without assigning an intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 318-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (655% higher).
The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01169194 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01169194 about?
NCT01169194 is a clinical study titled "Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)". The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will...
What is the current status of trial NCT01169194?
This trial is currently active not recruiting. The enrollment target is 2,400 participants. The study started on 2003-06. Estimated completion is 2027-08.
What conditions does trial NCT01169194 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease.
Who is sponsoring clinical trial NCT01169194?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01169194 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01169194's enrollment target sits among peer trials
2,400 2nd of 28 the highest of 28 other Inflammatory Bowel Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Bowel Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
-
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
RECRUITING
-
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia